8-KOther Events

CVS HEALTH Corp 8-K Report (Jan 13, 2004)

Filed January 13, 2004For Securities:CVS

Summary

CVS Corporation filed an 8-K on January 13, 2004, to report key sales results for the period ending January 3, 2004, and to provide updated guidance on diluted earnings per share (EPS) for the fiscal year ending January 3, 2004. This filing is crucial for investors as it offers insights into the company's recent performance and its outlook for the full fiscal year, enabling them to assess the company's operational momentum and financial trajectory. The press release, attached as an exhibit, likely contains specific sales figures and details about the revised EPS guidance. Investors should pay close attention to these numbers to understand how CVS is performing against expectations and to gauge the factors influencing the company's profitability. The disclosure of this information via an 8-K signifies its importance in providing timely updates to the market.

Key Highlights

  • 1CVS Corporation announced sales results for the period ended January 3, 2004.
  • 2The company issued revised diluted earnings per share (EPS) guidance for the fiscal year ended January 3, 2004.
  • 3The information was disseminated through a press release dated January 13, 2004, attached as Exhibit 99.1.
  • 4The filing indicates a proactive approach by CVS in updating investors on its financial performance and outlook.
  • 5The disclosure pertains to Item 12 (Disclosure of Results of Operations and Financial Condition) of the Form 8-K.
  • 6The report was filed on January 13, 2004, with the earliest event reported being January 13, 2004.
  • 7David B. Rickard, Executive Vice President, Chief Financial Officer and Chief Administrative Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to report CVS Corporation's sales results for the period ending January 3, 2004, and to update the company's diluted earnings per share (EPS) guidance for the fiscal year ending January 3, 2004. This provides investors with timely information on the company's performance and financial outlook.

The detailed sales and EPS information is contained within the press release dated January 13, 2004, which is attached as Exhibit 99.1 to this Form 8-K filing.

This information is important for investors because it offers a near real-time look at CVS's recent sales performance and provides an updated forecast for its profitability (EPS). This helps investors assess the company's operational health, compare its performance against expectations, and make informed investment decisions.

The information in this report is being furnished, not filed. This means it will not automatically be incorporated by reference into CVS's future registration statements under the Securities Act of 1933 unless specifically stated.